REMINDER: REBATE RULE WOULD DO NOTHING TO LOWER DRUG PRICES WHILE HIKING PREMIUMS ON SENIORS AND COSTING TAXPAYERS $200 BILLION
Administration Should Abandon Misguided Policy That Rewards Drug Companies’… Read More

Administration Should Abandon Misguided Policy That Rewards Drug Companies’… Read More
Big Pharma Completes Sweep of Beating Wall Street Expectations After 2020… Read More
Big Pharma Giant Sees Profits Jump After July Price Hikes Big Pharma giants… Read More
Drug Companies’ Anti-Competitive Gamesmanship Comes At Tremendous Cost To… Read More
Brand Name Big Pharma Giant Surpasses Expectations After Hiking Prices A new… Read More
Brand Name Drug Companies Beat Wall Street Expectations After Repeatedly… Read More
Price Hikes Fuel Q3 Earnings Beat For Brand Name Giant As millions of… Read More
Big Pharma Claims Misguided Proposal Would Benefit Patients, Facts Show It… Read More
Lawmakers Blast Big Pharma Executives During Two-Day Hearing on… Read More
Brand Name Drug Companies Must be Held Accountable for Pandemic Price Hikes… Read More
Misguided Measure Would Increase Medicare Part D Premiums, Cost Taxpayers More… Read More
Drug Companies Target PBMs and Rebates That Play a Critical Role in Lowering… Read More